Marksans Pharma Ltd. (MARKSANS)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
271. 45
-2.4
-0.8764%
₹
102.75B Market Cap
- P/E Ratio
2% Div Yield
675,579 Volume
- Eps
₹ 273.85
Previous Close Want to track MARKSANS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Marksans Pharma Ltd. (MARKSANS) Statistics
Valuation metrics
Market Cap 102.75B
Enterprise value 117.64B
Trailing P/E (ttm) 29.67
Forward P/E -
PEG ratio 3
Price/Sales (ttm) 4.21
Price/Book (mrq) 4.1
Enterprise Value/Revenue 3.99
Enterprise Value/EBITDA 18.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 897.07K
Average volume (90 days) 2.89M
Price summary
52-Week low 155
52-Week high 281.6
Beta -
50-Day moving average 263.53
200-Day moving average 210.11
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.8
Trailing annual dividend yield 0.0029%
5-Year annual dividend yield -
Payout ratio 0.09
Dividend Date 21 Aug 2025
Ex-Dividend Date 1 Aug 2025
Last split factor 10:1
Last split Date 11 Mar 2008
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.14%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 65.14
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 9.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 21.85
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 5.17%
Book value per share (mrq) 67.39
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
